Home Applications 050756 Application 050756
Type NDA
Sponsor BAUSCH Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 BENZACLIN BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE GEL;TOPICAL 5%;EQ 1% BASE Yes Yes 002 BENZACLIN BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE GEL;TOPICAL 5%;EQ 1% BASE No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N050756-001 BENZACLIN BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 N050756-002 BENZACLIN BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 84e616aacf4f…2026-08-18 06:07:40 2026-07 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL RLD 2000-12-21 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL AB RLD, RS 2000-12-21 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL AB RLD, RS 2000-12-21 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL AB RLD, RS 2000-12-21 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N050756-001 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL AB RLD, RS 2000-12-21 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N050756-002 BENZACLIN 5%;EQ 1% BASE GEL / TOPICAL 2007-04-20 74a2ff9319b5…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 6 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0187-5190 Benzaclin Clindamycin phosphate and benzoyl peroxide Valeant Pharmaceuticals North America LLC NDA Current 0187-5190 Benzaclin Clindamycin phosphate and benzoyl peroxide Bausch Health US LLC NDA Current 0187-5190 Benzaclin Clindamycin phosphate and benzoyl peroxide Bausch Health US LLC NDA Current 0187-5190 Benzaclin Clindamycin phosphate and benzoyl peroxide Bausch Health Americas, Inc. NDA Current 68682-190 Clindamycin phosphate and benzoyl peroxide Clindamycin phosphate and benzoyl peroxide Oceanside Pharmaceuticals NDA Current 68682-190 Clindamycin phosphate and benzoyl peroxide Clindamycin phosphate and benzoyl peroxide Oceanside Pharmaceuticals NDA Current